Magnevist was approved in 1988 by the FDA to “….facilitate the visualization of lesions and abnormal vascularity ….” The pharmaceutical was intended, in other words, for the diagnosis…
TrialSite’s founder Daniel O’Connor was able to briefly catch up with Ralph Lorigo, prominent advocate for patient’s rights and successful New York State attorney and partner of…
Is “Big Pharma” using the same tactics used by “Big Tobacco” to defeat ivermectin? Although researchers such as Richard Doll and Bradford Hill in the…
A Phase 1 clinical trial led by an investigator at NYU Langone and its Perlmutter Cancer Center report positive results from a new combination drug…
Researchers from the University of California, Santa Cruz (UCSC) share more information on a multi-mutated spike protein SARS-CoV-2 variant lineage that shares N501Y and P681H…
British pharmaceutical company AstraZeneca reports that data resulting from a late-stage clinical trial investigating whether its diabetes drug called Farxiga can treat patients hospitalized with…
A Marshall University investigator received just under a $400,000 grant to study the differences in brain development between males and females. Christopher Risher, PhD, assistant professor…
The National Institutes of Health (NIH)-backed ACTIV-2 clinical program has been billed by one of leading participating investigators as having the potential to “radically alter…
Vaccine centers around America put the brakes on further inoculations of the Johnson & Johnson COVID-19 vaccine over the last days due to a number…
Early phase clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with RET fusion-positive cancers,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
